| Literature DB >> 34063713 |
Nguyen D Tien1, Ståle Petter Lyngstadaas1, João F Mano2, Jonathan James Blaker1,3, Håvard J Haugen1.
Abstract
Chitosan has many useful intrinsic properties (e.g., non-toxicity, antibacterial properties, and biodegradability) and can be processed into high-surface-area nanofiber constructs for a broad range of sustainable research and commercial applications. These nanofibers can be further functionalized with bioactive agents. In the food industry, for example, edible films can be formed from chitosan-based composite fibers filled with nanoparticles, exhibiting excellent antioxidant and antimicrobial properties for a variety of products. Processing 'pure' chitosan into nanofibers can be challenging due to its cationic nature and high crystallinity; therefore, chitosan is often modified or blended with other materials to improve its processability and tailor its performance to specific needs. Chitosan can be blended with a variety of natural and synthetic polymers and processed into fibers while maintaining many of its intrinsic properties that are important for textile, cosmeceutical, and biomedical applications. The abundance of amine groups in the chemical structure of chitosan allows for facile modification (e.g., into soluble derivatives) and the binding of negatively charged domains. In particular, high-surface-area chitosan nanofibers are effective in binding negatively charged biomolecules. Recent developments of chitosan-based nanofibers with biological activities for various applications in biomedical, food packaging, and textiles are discussed herein.Entities:
Keywords: advanced textiles; biofunctionalized materials; chitosan nanofibers; dermal regeneration; skin graft substitute; sustainable food packaging; wound care
Year: 2021 PMID: 34063713 PMCID: PMC8125268 DOI: 10.3390/molecules26092683
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1(A) The production of chitosan: Chitosan is made by deacetylation of chitin extracted from crustacean exoskeleton. Chitosan nanofibers are commonly fabricated by (B) electrospinning or (C) solution blow spinning, usually from chitosan dissolved in acetic acid. The principle of electrospinning is the induction of a liquid jet from a syringe nozzle using a high voltage, while solution blow spinning uses a high-pressure inert gas as a driving force. The solvent evaporates at the nozzle, and the polymer chains are stretched and travel the tip-to-collector distance, where the solidified nanofibers accumulate on the collectors.
Figure 2(A) An SEM picture of electrospun chitosan-PEO nanofibers (ChNFs) obtained from a 90/10 (w/w) solution in 50% acetic acid. (B) In vitro antibacterial activity of 1-cm2 and 2.5-cm2 swatches of ChNFs against E. coli, L. innocua, S. aureus, and S. Typhimurium compared to a negative control membrane (Ctrl−). The arrows indicate total inhibition of E. coli, L. innocua, and S. aureus growth. The wider the area of ChNFs (i.e., larger chitosan content), the better the effect against S. Typhimurium. (C) In situ antibacterial activity of ChNFs-based packaging (ChNFP) against E. coli compared to negative control (Ctrl−) of inoculated meat and positive control of inoculated meat wrapped in neat conventional packaging (NP) after seven days of raw meat storage at 4 °C. (D) Appearance of red meat wrapped in ChNFP and NP one week before and after grinding. Reprinted with permission from [66], copyright 2018 Wiley.
Figure 3(A) Schematic illustration of the wet spinning process for yarn preparation adopted from [74]. (B) Chitosan microfibers wet spun from an 8.5 wt% solution. (C) The constructed knitted fabric. Reprinted with permission from [75], copyright 2014 Taylor & Francis.
Figure 4Micrograph images of surface structures in (A) chitosan fiber and (B) chitosan/cotton yarn. (C) Illustration of the blending methods. The yarn fiber blend showed higher (D) tenacity and (E) elongation than the yarn sliver blend at all chitosan fiber lengths. Reprinted with permission from [80,81], copyright 2014 & 2017 SAGE Publications.
Figure 5(A) A protective cosmeceutical mask for facial skincare after burns based on (B) a chitosan nanofiber membrane. (C) Schematic illustration of the nanofiber layer on the skin surface. Depending on the materials and active ingredients used in formulation for manufacturing, the nanofiber face mask can exhibit various functionalities, including increased contact area with the skin, protection of the skin from microsized polluted particles and bacteria, and maintenance of skin conditioning and moisture.
Figure 6The wound healing process of (A) an open wound covered with (B) an antimicrobial wound dressing. When the antimicrobial dressing covers the wound bed, it acts as a barrier to prevent bacteria and viruses from invading the wound. Dressings with embedded functional agents can promote the healing rate and stimulate the immune system to speed up skin regeneration in immunocompromised patients. Reprinted with permissions from [101], copyright 2018 Elsevier. An example in (C) shows chitosan-based nanofibers with 0.3% w/v of polyhexanide (a commonly used wound disinfectant) embedded, used to fabricate an antimicrobial surface on a surgical dressing. Reprinted with permissions from [102], copyright 2020 Springer. (D) In vivo wound healing in a mouse model using a PCL-chitosan nanofibrous dressing with or without incorporated nitric oxide. The nitric oxide-containing material promotes faster wound closure, as illustrated in (E) by the percentage of open wound area and in (F) by the percentage of wound closure. Reprinted with permissions from [109], copyright 2018 Elsevier. ** p < 0.01, *** p < 0.001, ## p < 0.05.
Figure 7A bilayer scaffold composed of a nanofiber mat and a hydrogel mimics the layered nature of skin. The chitosan-based nanofiber was prepared by electrospinning, while the hydrogel was synthesized by photopolymerization. (A) Human fibroblasts were encapsulated in the gel and poured into a mold with the nanofiber mat placed on the bottom. (B) After a short incubation period, the hydrogel was flipped over with the nanofiber mat side up, and keratinocyte cells were seeded onto the nanofiber surface. After co-culturing, encapsulated fibroblasts (blue) proliferated in the hydrogel matrix, while keratinocyte cells (red) formed a layer on top of the fibrous scaffold, mimicking the epidermis and the dermis. (C) A cross-section of the cellularized bilayered material. Reprinted with permissions from [128], copyright 2017 Elsevier. (D) A 3D scaffold made from a nanofiber-hydrogel composite and captured by confocal microscopy. The fibrin-coated nanofiber mat (green) enabled the fibroblasts (red) to migrate from the nanofibers and into the collagen hydrogel (middle layer), mimicking the skin’s dermis. Different from the 3D scaffold in (B), the hydrogel in (D) constitutes the top layer supporting the embedded keratinocytes (yellowish), mimicking the skin’s epidermis. Reprinted with permissions from [129], copyright 2019 Dove Medical Press.
Commercial chitosan-based fiber products on the medical wound care market.
| Material | Product Name | Specification | Approved Market | Manufacturer |
|---|---|---|---|---|
| Chitosan | CeloxTM Rapid | Hemostatic dressings contain activated chitosan bonded to a high-density gauze | USA, EU | Medtrade Products Ltd., Crewe, UK |
| Chitosan | axiotstat® | Hemostatic dressings have mucoadhesion due to charge | USA, EU | Axio Biosolutions Pvt. Ltd., Ahmedabad, India |
| Chitosan | ChitoFlex® PRO | Hemostatic dressings for the treatment of moderate to severely bleeding wounds | USA, EU | Tricol Biomedical, Inc., Portland, Oregon, USA |
| Chitosan | ChitoSAMTM100 | Hemostatic dressings optimized to stop the bleed fast | USA, EU | SAM® Medical, Tualatin, Oregon, USA |
| Chitosan | ChitoClot Gauze | Hemostatic dressings reduce bleeding time | USA, EU, Taiwan | BenQ Materials Corporation, Taoyuan, Taiwan |
| Chitosan | Chitoskin® | A non-woven chitosan-based skin substitute | China | Hainan Xinlong Nonwovens Co., Ltd., Haikou, China |
| Chitosan | Chito-Seal | Hemostatic dressings for bleeding wounds | USA | Abbott Vascular, Inc., Chicago, Illinois, USA |
| Chitosan | Clo-Sur P.A.D® | A non-woven topical pad accelerates hemostasis | USA | Scion BioMedical, Miami, Florida, USA |
| Chitosan | ExcelArrest® XT | Hemostatic dressings made of modified chitosan that accelerates the clotting process | USA, EU | Hemostasis, LLC, Saint Paul, Minnesota, USA |
| Chitosan/alginate | Tromboguard® | Act as the contact layer of a multilayer hemostatic dressing | EU | TRICOMED S.A., Łódź, Poland |
| Chitosan/rayon | ChiPro face mask | Chitosan face masks contain 45% chitosan and 55% rayon | Germany | ChiPro GmbH, Bremen, Germany |
| Chitosan/polynosic | Chitopoly® | Antimicrobial wears made of chitosan and polynosic fiber | Japan | Fuji Spinning Co., Ltd., Tokyo, Japan |
| Chitosan/viscose | Crabyon® | The Crabyon® fiber that made of chitosan and viscose used for the textile market | Switzerland | Swicofil AG, Lucerne, Switzerland |
| Chitosan | Chitopack C® | Cotton-like chitosan prepared by wet spinning | Japan | Eisai Co., Ltd., Tokyo, Japan |
Summary of chitosan-based micro/nanofibers for sustainable food packaging, smart textiles, cosmetics, biomedical applications, and their characteristics.
| Micro/Nanofibers | Composition | Fiber Diameter | Application | Remark | Reference |
|---|---|---|---|---|---|
| Chitosan/PEO | (10−90):(90−10) ( | <500 nm | Food packaging Wound healing | - Developed as the inner part of multilayer packaging that preserves the quality and freshness of meat | [ |
| Chitosan/PEO/HAL | 1:1 ( | 70−160 nm | Bone tissue engineering | High tensile strength with a porous structure and good biocompatibility | [ |
| Chitosan/PEO/PE 1 | (80−20):(20−80) ( | 211−421 nm | Food packaging | Preserve and enhance the shelf life of beef | [ |
| Chitosan/PEO/TTO 2 | 20:2 (mg/mL): (30−70% TTO) ( | 150−300 nm | Food packaging | Prevent the microbial contamination by | [ |
| Chitosan/PVA/tea extract/GO 3 | (10−50):(90−50) ( | 100−120 nm | Food packaging | Have bacteriostasis and deoxidizing ability that prolong the shelf life of food | [ |
| Chitosan/PVA/ZnO (or Ag, Cu, | 1:4 ( | 270−320 nm | Wound dressings | Have good antibacterial and antioxidant properties that served as dressings for diabetic wounds | [ |
| Chitosan/PVA/silk fibroin | 40:60 ( | 126−643 nm | Wound dressings | Good biocompatibility with mouse fibroblasts (L929) | [ |
| Chitosan/thymol/liquid smoke | 6.75% ( | 72−132 nm | Food packaging | Delay growth of mesophilic bacteria in fish fillets | [ |
| Chitosan/xanthan gum/curcumin | 3%:0.75%:2% ( | 750−910 nm | Functional packaging | - Stable nanofibrous structures in aqueous media | [ |
| Chitosan + gelatin | 8.5 wt% (chitosan) | 20 µm (chitosan) | Functional textile | - Chitosan microfibers coated gelatin nanofibers- High mechanical strength with the cell-seeding ability | [ |
| Chitosan/gelatin/Fe3O4 (or cinnamon extract) | 1:1( | 307−435 nm | Wound dressings | Enhance mechanical and antibacterial properties | [ |
| Chitosan/mPEG | 1:(1−5) ( | - | Smart textile | - High tensile strength | [ |
| Chitosan/glycine chloride ionic liquid | 6.5%:4% ( | 20 µm | Smart textile | Strong mechanical properties due to high orientation and crystallinity of fibers | [ |
| Chitosan + cotton | 50:50 | - | Functional textile | - High tensile strength | [ |
| Chitosan + PAN | 12:88, 30:70, 50:50 | - | Functional textile | - High tenacity | [ |
| Chitosan/nylon-6 | 3%:21% ( | 200−350 nm | Wound healing | Fabricated as core/shell antimicrobial nanofibers | [ |
| Chitosan/PLA | 50:50 ( | 840 nm | Wound healing | Suppress the adhesion of bacteria | [ |
| Chitosan/PCL/aloe vera | (1−3):(8−5) ( | <100 nm | Wound dressings | High antibacterial performance and biocompatibility | |
| Chitosan/PPC 4/curcumin | 1:2 ( | 200−400 nm | Wound healing | Enhance wound healing efficacy | [ |
| Chitosan/HAp | 70:30 ( | 195−240 nm | Bone tissue engineering | Stimulate the bone forming ability | [ |
| Chitosan/collagen/PEO/polypyrrole | 2.6:0.6:2.1 ( | 83−140 nm | Skin tissue engineering | Conductive nano-scaffolds with high biocompatibility | [ |
1 PE: pomegranate peel extract, 2 TTO: tea tree oil liposomes, 3 GO: glucose oxidase, 4 PPC: poly (propylene carbonate).